. Author manuscript; available in PMC: 2013 Jul 28.

Published in final edited form as: Cancer Lett. 2012 Mar 2;320(2):180–188. doi: 10.1016/j.canlet.2012.02.031

Table 1.

Patient information.

Group	Number of Patients	Total number of biopsies tested(range per patient)	Age (Mean ± SD)	Duration of disease (Mean ± SD)	Age of Onset (Mean ± SD)
Non-UC3	8	8(1)	41.9 ± 7.6
UC Non-Progressors	10	17 (1–4)	48.5 ± 14.3	19.6 ± 7.1	28.2 ± 9.9
UC Progressors	10	58 (2–9)	41.2 ± 11.2	14.3 ± 7.2 ^*	24.9 ± 9.0 ^*

Shown are the number of patients per group with the number of biopsies studied per patient, the average age of patients, duration of disease in years (±standard deviation), and average ages of onset (±standard deviation).

denotes that information was unavailable for one patient